Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Cytokines are important for immune responses and treating diseases, but they can cause side effects like fever and skin issues.

Stopping TNFα inhibitors can help children regrow hair lost due to the medication.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

Some drugs used to treat immune conditions may cause different types of hair loss.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Some drugs for inflammation may cause psoriasis-like hair loss.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Inhibiting certain enzymes made female rats more sensitive to low-level pain.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.